Anthem may be calling off its $48 billion bid for rival health insurer Cigna after facing stiff regulatory challenges, according to a report from the New York Post.
The Post said it had learned that Anthem “appears ready to walk away from the deal,” though the company officially says it is not currently weighing a termination of the merger.
US antitrust regulators have been skeptical of the deal and are concerned that the acquisition would lead to too muchindustry consolidation, resulting in less competition and higher premium prices for customers.
The deal would combine the No. 2 and No. 4 health insurers in the US, creating a behemoth with 53 million customers in commercial, government, consumer, and other kinds of health insurance plans.
Full Content: NY Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkey Fines Meta $10.4 Million for Abusing Market Dominance
May 6, 2024 by
CPI
Canadian Watchdog Launches Inquiry into Lululemon’s Greenwashing Practices
May 6, 2024 by
CPI
Massachusetts Supreme Court Deliberates Ballot Redefining Gig Worker Status
May 6, 2024 by
CPI
European Commission Approves Nippon Steel’s $14.9 Billion Buyout of U.S. Steel
May 6, 2024 by
CPI
Banco Sabadell Rejects Rival BBVA Merger Proposal
May 6, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI